BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 9066565)

  • 1. Peritoneovenous shunting for malignant ascites.
    Wickremesekera SK; Stubbs RS
    N Z Med J; 1997 Feb; 110(1037):33-5. PubMed ID: 9066565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneovenous shunts for malignant ascites.
    Sonnenfeld T; Tydén G
    Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Denver type for peritoneovenous shunting of malignant ascites.
    Roussel JG; Kroon BB; Hart GA
    Surg Gynecol Obstet; 1986 Mar; 162(3):235-40. PubMed ID: 2420017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneovenous shunting is an effective treatment for intractable ascites.
    Sooriakumaran P; McAndrew HF; Kiely EM; Spitz L; Pierro A
    Postgrad Med J; 2005 Apr; 81(954):259-61. PubMed ID: 15811892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneovenous shunts for palliation of malignant ascites.
    Mamada Y; Yoshida H; Taniai N; Bandou K; Shimizu T; Kakinuma D; Mizuguchi Y; Ishikawa Y; Akimaru K; Tajiri T
    J Nippon Med Sch; 2007 Oct; 74(5):355-8. PubMed ID: 17965529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneovenous shunts--devices of last resort.
    Shepherd KE; Miller BJ
    Can J Surg; 1988 Nov; 31(6):444-7. PubMed ID: 3179855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneovenous shunt in malignant ascites. The Bordet Institute experience from 1975-1998.
    Tueche SG; Pector JC
    Hepatogastroenterology; 2000; 47(35):1322-4. PubMed ID: 11100342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease.
    Vadeyar HJ; Doran JD; Charnley R; Ryder SD
    Br J Surg; 1999 Jul; 86(7):882-5. PubMed ID: 10417558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneovenous shunting for cirrhotic versus malignant ascites.
    Kostroff KM; Ross DW; Davis JM
    Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved quality of life for malignant ascites patients by Denver peritoneovenous shunts.
    Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Nakao A; Soda M; Shimizu N
    Anticancer Res; 2006; 26(3B):2393-5. PubMed ID: 16821622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience.
    Hussain FF; Meer ZF; Lopez AJ
    Cardiovasc Intervent Radiol; 2004; 27(4):325-8. PubMed ID: 15346206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous implant of Denver peritoneovenous shunt: a new opportunity for the interventional radiologist].
    Spreafico C; Patelli G; Lanocita R; Di Tolla G; Marchianò A; Frigerio L; Garbagnati F; Ticha V; Damascelli B
    Radiol Med; 2001 Sep; 102(3):154-8. PubMed ID: 11677458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of peritoneovenous shunt for malignant ascites.
    Lokich J; Reinhold R; Silverman M; Tullis J
    Cancer Treat Rep; 1980; 64(2-3):305-9. PubMed ID: 6157465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantation of a Denver shunt by left subclavian approach for preventing kinking.
    Oida T; Mimatsu K; Kawasaki A; Kanou H; Kuboi Y; Matsuoka S; Amano S
    Hepatogastroenterology; 2009; 56(93):1074-7. PubMed ID: 19760944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant ascites in patients with advanced cancer: peritoneovenous shunt versus paracentesis.
    Seike M; Maetani I; Sakai Y
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2161-6. PubMed ID: 18031375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneovenous shunt for palliation of gynecologic malignant ascites.
    Faught W; Kirkpatrick JR; Krepart GV; Heywood MS; Lotocki RJ
    J Am Coll Surg; 1995 Apr; 180(4):472-4. PubMed ID: 7536598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
    Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
    Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.